Zhi-jun Wu
P.R. China
Nantong, 226361, China
Nantong, 226361, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells.
Journal: World journal of clinical cases
Published: December 13, 2021
MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65.
Journal: Molecular therapy oncolytics
Published: October 31, 2020
Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4.
Journal: Cell death discovery
Published: September 17, 2020
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B.
Journal: Molecular therapy oncolytics
Published: August 27, 2020
KDM5A silencing transcriptionally suppresses the FXYD3-PI3K/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation.
Journal: Journal of cellular and molecular medicine
Published: May 06, 2020
Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.
Journal: Molecular therapy. Nucleic acids
Published: February 19, 2020
Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
Journal: Journal of cellular and molecular medicine
Published: December 05, 2019
Prognosis for intrahepatic cholangiocarcinoma patients treated with postoperative adjuvant transcatheter hepatic artery chemoembolization.
Journal: Current problems in cancer
Published: December 02, 2019
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
Journal: Molecular therapy oncolytics
Published: January 03, 2019
Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
Journal: Cancer letters
Published: February 22, 2018
Last Updated: 09/26/2026